Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 04:15PM GMT
Release Date Price: $104.1 (-1.99%)
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Great. Well, good afternoon, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst at Morgan Stanley. We're very pleased to be hosting Moderna this afternoon. We have Stephane Bancel, who is the company's CEO. Stephane, thanks so much for being here.

Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. Stephane, thanks so much again for your time today. Really looking forward to catching up again as it's been a while, as we were just talking about before.

Questions & Answers

Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Maybe I thought the place to start, just high level, give us an update on kind of strategic focus for the company here and capital allocation priorities as obviously, we're shifting to this kind of post-pandemic world here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot